Jasmin Ray
Long Beach, CANPI 1649084203
Payments from drug & device makers
Across 100 payments — averaging $37.60 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Livanova USA, Inc.$1K
- UCB, Inc.$833
- SK Life Science, Inc.$252
- Neurelis, Inc.$222
- AbbVie$199
- Corium, LLC$110
- plus $1K from 19 others
What the payments were for
- Travel & lodging$88123%
- Food & beverage$2,87877%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Livanova USA, Inc. | 3 | $1,142 |
| UCB, Inc. | 23 | $833 |
| SK Life Science, Inc. | 6 | $252 |
| Neurelis, Inc. | 12 | $222 |
| AbbVie | 8 | $199 |
| Corium, LLC | 8 | $110 |
| Axsome Therapeutics, Inc. | 4 | $108 |
| Harmony Biosciences LLC | 2 | $88 |
| Acadia Pharmaceuticals Inc | 4 | $88 |
| Collegium Pharmaceutical, Inc. | 4 | $86 |
| Noven Therapeutics, LLC | 3 | $73 |
| Jazz Pharmaceuticals Inc. | 3 | $67 |
| Johnson & Johnson | 2 | $54 |
| Neurocrine Biosciences, Inc. | 2 | $53 |
| Tris Pharma Inc | 3 | $51 |
| Lundbeck LLC | 2 | $50 |
| Novartis | 2 | $49 |
| CSL Behring | 2 | $49 |
| Intrabio Inc | 1 | $43 |
| Biogen | 1 | $29 |
| Azurity Pharmaceuticals, Inc. | 1 | $28 |
| Teva Pharmaceuticals USA, Inc. | 1 | $26 |
| Catalyst Pharmaceuticals, Inc. | 1 | $25 |
| Forte Bio-pharma LLC | 1 | $18 |
| Neos Therapeutics, LP | 1 | $16 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- VNS Therapy$1,142
- XCOPRI$125
- Briviact$125
- Fintepla$123
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.